Reliance Industries, through its subsidiary Reliance Strategic Business Ventures (RSBVL), has acquired the oncology-focused healthcare platform Karkinos for Rs 375 crore. The acquisition was ...

Reliance Industries (RIL) shares will remain in focus on Monday after the company on Saturday announced the acquisition of technology-led oncology platform Karkinos Healthcare for Rs 375 crore ...

The development follows the approval of a resolution plan for Karkinos Healthcare by NCLT after it entered the Corporate Insolvency Resolution Process (CIRP) in May. Tata Group to invest Rs 110 ...

New Delhi [India], December 30 (ANI): The acquisition of the oncology platform Karkinos Healthcare by Reliance Industries Limited has added another stack to the Indian conglomerate's diagnostic and ...

The crab figure holds meaning, as cancerous tumors were likened to cancers in ancient times, which is why the disease was named 'karkinos'. "Today, the word 'cancer' used also takes its name from ...

Karkinos was incorporated in India on July 24, 2020, and is in the business of providing technology-driven innovative solutions for the early detection, diagnosis, and management of cancer.

The preferred method is to just download and extract the latest release. Karkinos will manage updates by itself from that point on. Alternatively, you can clone this repository. Once you have Karkinos ...

Last week, Reliance bought oncology platform Karkinos Healthcare for Rs 375 crore, adding another stack to its diagnostic and digital healthcare ecosystem, Morgan Stanley said in a report.

Reliance Industries has bought the technology-driven oncology platform Karkinos Healthcare for ₹375 crore through Reliance Strategic Business Ventures. The deal consists of ₹10 crore equity ...

Karkinos is a company based in Mumbai, Maharashtra, India, operating in the healthtech sector. Founded in 2020, it now employs 463 individuals. The company was established by Manish Thakkar ...

Set up during the pandemic, Karkinos works with various healthcare institutions in the oncology ecosystem, a statement from the startup said. Rakuten Medical's first pipeline drug developed on its ...